MedPath

ERCP Plus Laparoscopic Cholecystectomy Versus Laparoscopic Common Bile Duct Exploration and Cholecystectomy

Not Applicable
Completed
Conditions
Common Bile Duct Calculi
Interventions
Procedure: Endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy
Procedure: aparoscopic common bile duct exploration and laparoscopic cholecystectomy
Registration Number
NCT05901363
Lead Sponsor
South Valley University
Brief Summary

Around 10-18% of patients undergoing cholecystectomy for gallstones have common bile duct (CBD) stones. Currently, various procedures for the treatment of cholecystocholedocholithiasis are available including open cholecystectomy plus open common bile duct exploration (OC+OCBDE), laparoscopic cholecystectomy plus laparoscopic common bile duct exploration (LC+LCBDE), may be trans-cystic or trans-choledochal, and laparoscopic cholecystectomy plus endoscopic retrograde cholangiopancreatography (LC+ERCP), which may be performed pre, at, or after LC.

Detailed Description

Around 10-18% of patients undergoing cholecystectomy for gallstones have common bile duct (CBD) stones. Currently, various procedures for the treatment of cholecystocholedocholithiasis are available including open cholecystectomy plus open common bile duct exploration (OC+OCBDE), laparoscopic cholecystectomy plus laparoscopic common bile duct exploration (LC+LCBDE), may be trans-cystic or trans-choledochal, and laparoscopic cholecystectomy plus endoscopic retrograde cholangiopancreatography (LC+ERCP), which may be performed pre, at, or after LC.

Single-session treatment of gallbladder and CBD stones is safe, efficient, shortens hospital stay, and is less expensive than staged procedures.

Although there is some evidence suggesting that LCBDE may be associated with a lower rate of retained stones compared with ERCP, previous studies comparing LCBDE with ERCP and stone extraction have collectively failed to demonstrate the superiority of one approach over the other.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
218
Inclusion Criteria
  1. Patients diagnosed with cholecystocholedocholithiasis
  2. American Society of Anesthesiologists (ASA) scores of I-III
  3. Age 20-70 years.
Exclusion Criteria
  1. cholangitis,
  2. acute biliary pancreatitis,
  3. suspected Mirizzi syndrome,
  4. suspected hepatobiliary malignancy,
  5. perforated gallbladder,
  6. biliary peritonitis,
  7. intrahepatic stones,
  8. pregnancy,
  9. previous cholecystectomy,
  10. altered anatomy such as Billroth II reconstruction or any form of Roux-en-Y reconstruction that interfere with the endoscopic approach,
  11. Contraindications to laparoscopic surgery as severe liver cirrhosis or upper abdominal surgery were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomyEndoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomyendoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy
laparoscopic common bile duct exploration and laparoscopic cholecystectomyaparoscopic common bile duct exploration and laparoscopic cholecystectomy-
Primary Outcome Measures
NameTimeMethod
success rate2 years

successful laparoscopic cholecystectomy and successful common bile duct stone extraction

Secondary Outcome Measures
NameTimeMethod
The total cost of treatment30 days
mortality3 years

death of patient

Hospital stay30 days

the length of hospital stay from the day of admission to the day of discharge

operative timefrom 1 to 5 hours

the overall time of the procedure

morbidity3 years

any intraoperative or postoperative adverse event

the number of hospital readmission3 years
the number of postoperative intervention3 years

Trial Locations

Locations (1)

Mohammed Ahmed Omar

🇪🇬

Qinā, Qena, Egypt

© Copyright 2025. All Rights Reserved by MedPath